REGULATORY
MHLW Announces Results of Reexamination for Iressa, Remicade as Category I
At a meeting on December 1, the Second Committee on Drugs of the Pharmaceutical Affairs and Food Sanitation Council (PAFSC) at the Ministry of Health, Labor, and Welfare (MHLW; Korosho) reported the results of the reexamination on 10 drugs including…
To read the full story
REGULATORY
- TNF Inhibitors, Cancer Drugs Flagged in PMDA Risk Review
March 30, 2026
- Japan Ranks 9th Among 10 in AI Analysis of EFPIA Pharma Strategy Report
March 27, 2026
- MHLW Says Trial Recruitment Info Not Deemed Advertising Under PMD Act
March 27, 2026
- AMED Warns Projects without Japan Return May Miss Startup Funding
March 26, 2026
- Japan Cabinet Approves National MCM Strategy to Boost Pandemic Response
March 25, 2026
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…





